JR-141

Phase 2/3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Mucopolysaccharidosis II

Conditions

Mucopolysaccharidosis II

Trial Timeline

Aug 1, 2018 → Feb 20, 2020

NCT ID

NCT03568175

About JR-141

JR-141 is a phase 2/3 stage product being developed by JCR Pharmaceuticals for Mucopolysaccharidosis II. The current trial status is completed. This product is registered under clinical trial identifier NCT03568175. Target conditions include Mucopolysaccharidosis II.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (5)

NCT ID	Phase	Status	Start	Completion	Indication
NCT05594992	Phase 3	Recruiting	Feb 22, 2023	Feb 28, 2028	Mucopolysaccharidosis II
NCT04348136	Phase 2/3	Active	Sep 1, 2019	Mar 31, 2030	Mucopolysaccharidosis II
NCT03708965	Phase 2	Active	Jan 1, 2019	Dec 31, 2027	Mucopolysaccharidosis II
NCT03568175	Phase 2/3	Completed	Aug 1, 2018	Feb 20, 2020	Mucopolysaccharidosis II
NCT03128593	Phase 1/2	Completed	Mar 30, 2017	Oct 4, 2017	Mucopolysaccharidosis II

Competing Products

20 competing products in Mucopolysaccharidosis II

See all competitors

Product	Company	Stage	Hype Score
Odiparcil	Inventiva	Phase 2	47
anakinra	Swedish Orphan Biovitrum	Phase 1/2	40
laronidase	Sanofi	Approved	84
Laronidase	Sanofi	Approved	84
Aldurazyme (Recombinant Human Alpha-L-Iduronidase) + Aldurazyme (Recombinant Human Alpha-L-Iduronidase)	Sanofi	Phase 2	51
Aldurazyme (Recombinant Human Alpha-L-Iduronidase) + Aldurazyme (Recombinant Human Alpha-L-Iduronidase) + Aldurazyme (Recombinant Human Alpha-L-Iduronidase) + Aldurazyme (Recombinant Human Alpha-L-Iduronidase)	Sanofi	Approved	84
Laronidase + Cyclosporine A (CsA) + Azathioprine (Aza)	Sanofi	Phase 1/2	40
Aldurazyme (Recombinant Human Alpha-L-Iduronidase)	Sanofi	Phase 3	76
rhIDU (recombinant human-Alpha-L-Iduronidase) + Placebo	Sanofi	Phase 3	76
Aldurazyme + Aldurazyme + placebo	Sanofi	Phase 3	76
Laronidase	Sanofi	Approved	84
JR-441 + JR-441 + JR-441	JCR Pharmaceuticals	Phase 1/2	40
JR-446	JCR Pharmaceuticals	Phase 1/2	40
JR-171	JCR Pharmaceuticals	Phase 1/2	40
JR-141	JCR Pharmaceuticals	Phase 2	51
JR-141 + Idursulfase + JR-141 or Idursulfase	JCR Pharmaceuticals	Phase 3	76
JR-141	JCR Pharmaceuticals	Phase 3	76
JR-171 (lepunafusp alfa)	JCR Pharmaceuticals	Phase 1/2	40
JR-141	JCR Pharmaceuticals	Phase 1/2	40
JR-141	JCR Pharmaceuticals	Phase 2/3	64

Other Products from JCR Pharmaceuticals

JR-141 + Idursulfase + JR-141 or IdursulfasePhase 3

JR-141Phase 3

JR-141Phase 2/3

JR-141Phase 2

JR-141 + JR-141 + JR-141Phase 2